Kristian W Pajtler Selected Research

Kristian W Pajtler Research Topics

Disease

39	Neoplasms (Cancer) 04/2024 - 07/2012
21	Ependymoma 10/2023 - 01/2016
7	Glioma (Gliomas) 04/2024 - 03/2017
6	Medulloblastoma 11/2021 - 07/2012
5	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2016
4	Neuroblastoma 01/2017 - 05/2013
3	Disease Progression 12/2021 - 09/2017
2	Li-Fraumeni Syndrome 01/2022 - 01/2017
2	Carcinogenesis 01/2021 - 01/2019
1	Rhabdomyosarcoma 01/2024
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 03/2023
1	Fibrosarcoma 01/2022
1	Oligodendroglioma 01/2022
1	Choroid Plexus Papilloma 12/2021
1	Pleomorphic Adenoma 11/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2021
1	Multiple Myeloma 06/2021
1	Exanthema (Rash) 09/2020
1	Paronychia 09/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Breast Neoplasms (Breast Cancer) 02/2019
1	Hemolysis 02/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Diffuse Intrinsic Pontine Glioma 01/2019
1	Genomic Instability 06/2016
1	Chromothripsis 06/2016
1	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 03/2016
1	Primitive Neuroectodermal Tumors (PNET) 02/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Spontaneous Remission 08/2013

Drug/Important Bio-Agent (IBA)

10	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2020
8	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2012
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2016
5	Messenger RNA (mRNA)IBA 01/2021 - 07/2012
4	Cell-Free Nucleic AcidsIBA 01/2024 - 02/2019
3	Conditioned Culture MediaIBA 04/2024 - 08/2013
3	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2024 - 09/2016
3	Etoposide (VP 16)FDA LinkGeneric 01/2024 - 01/2016
3	ChromatinIBA 01/2021 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2017
2	Vincristine (Oncovin)FDA LinkGeneric 01/2024 - 01/2022
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023 - 11/2014
2	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 01/2023
2	Mitogen-Activated Protein KinasesIBA 01/2023 - 09/2020
2	Histones (Histone)IBA 11/2019 - 05/2013
2	Lysine (L-Lysine)FDA Link 11/2019 - 05/2013
2	MicroRNAs (MicroRNA)IBA 02/2019 - 05/2015
2	Small Interfering RNA (siRNA)IBA 01/2018 - 07/2012
2	nutlin 3IBA 09/2016 - 07/2012
2	trkA ReceptorIBA 11/2014 - 08/2013
1	CytokinesIBA 04/2024
1	NucleotidesIBA 01/2024
1	Small Cytoplasmic RNAIBA 01/2024
1	Carboplatin (JM8)FDA LinkGeneric 01/2024
1	Ifosfamide FDA LinkGeneric 01/2024
1	SynaptophysinIBA 03/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	tyrosine receptor (receptor, tyrosine)IBA 01/2023
1	ulixertinibIBA 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2021
1	selinexorIBA 06/2021
1	TransposasesIBA 01/2021
1	Arsenic Trioxide (Trisenox)FDA Link 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	entrectinibIBA 12/2020
1	trametinibIBA 09/2020
1	NivolumabIBA 06/2020
1	entinostat (MS 275)IBA 06/2020
1	ProteomeIBA 01/2020
1	NeurocalcinIBA 01/2020
1	Polycomb Repressive Complex 2IBA 11/2019
1	Enhancer of Zeste Homolog 2 ProteinIBA 11/2019
1	dipinacoline glutamateIBA 01/2019
1	NFI Transcription FactorsIBA 01/2019
1	TEA Domain Transcription FactorsIBA 01/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2017
1	GSK 461364IBA 01/2017
1	BI 2536IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2017
1	Polo-Like Kinase 1IBA 01/2017
1	vasectrin IIIIBA 01/2017
1	Sirtuin 1IBA 05/2015
1	Differentiation AntigensIBA 11/2014
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2014
1	EnzymesIBA 05/2013
1	Histone DemethylasesIBA 05/2013

Therapy/Procedure

19	Therapeutics 01/2024 - 05/2013
6	Drug Therapy (Chemotherapy) 01/2024 - 01/2018
5	Radiotherapy 01/2024 - 01/2016
1	Metastasectomy 01/2024
1	Aftercare (After-Treatment) 01/2023
1	Combined Modality Therapy 12/2020
1	Drug Tapering 09/2020
1	Precision Medicine 01/2019
1	Craniospinal Irradiation 01/2019
1	Transcutaneous Electric Nerve Stimulation (TENS) 06/2016
1	Cytoreduction Surgical Procedures 01/2016